1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Code

Showing 1,267 results.

Thumbnail for Integrated Tissue Transcriptomic Profiling Reveals Immune and microRNA Dysregulation in Gastrointestinal Acute Graft-Versus-Host Disease

CT - 543

Integrated Tissue Transcriptomic Profiling Reveals Immune and microRNA Dysregulation in Gastrointestinal Acute Graft-Versus-Host Disease

Rachel Crossland

Poster Presenter: Rachel Crossland

Thumbnail for Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

CT - 544

Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

$Thumbnail for The selective PI3Kδ inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from na?ve and JAK inhibitor-refractory/resistant patients with myelofibrosis$

MPN - 545

The selective PI3Kδ inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from na?ve and JAK inhibitor-refractory/resistant patients with myelofibrosis

Giusy Di Conza

Poster Presenter: Giusy Di Conza

Thumbnail for Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients with Hematologic Malignancies: A Real-World Propensity-Matched Analysis

CML - 547

Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients with Hematologic Malignancies: A Real-World Propensity-Matched Analysis

Antonio Arciniegas

Poster Presenter: Antonio Arciniegas

MM - 548

Navigating Bispecifics Outpatient Step-Up Dosing: A Roadmap to Help Improve Safety and Access in the Real-World (NORTHSTAR)

Muhamed Baljevic

Poster Presenter: Muhamed Baljevic

Thumbnail for Two-Year Rituximab Maintenance vs Observation After First-Line Treatment With Bendamustine Plus Rituximab (B-R) in Patients With Waldenström’s Macroglobulinemia: Results of a Prospective, Randomized Multicenter Phase 3 Study (StiL NHL7-2008 MAINTAIN Trial

IBCL - 549

Two-Year Rituximab Maintenance vs Observation After First-Line Treatment With Bendamustine Plus Rituximab (B-R) in Patients With Waldenström’s Macroglobulinemia: Results of a Prospective, Randomized Multicenter Phase 3 Study (StiL NHL7-2008 MAINTAIN Trial

Mathias Rummel

Poster Presenter: Mathias Rummel

AML - 550

Plasma Cytokeratin 18 (Ck-18) Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

aliaa nabil

Poster Presenter: aliaa nabil

Thumbnail for Real-World Insights Into Demographic Profiles and Barriers to Hematopoietic Stem Cell Transplantation in Pakistan: A Single-Center Experience

AML - 551

Real-World Insights Into Demographic Profiles and Barriers to Hematopoietic Stem Cell Transplantation in Pakistan: A Single-Center Experience

Maleeha Akbar

Poster Presenter: Maleeha Akbar

Thumbnail for Administering Tafasitamab, Lenalidomide and Rituximab for Follicular Lymphoma: a Single Institution Experience From the Phase 3 inMIND Study

IBCL - 552

Administering Tafasitamab, Lenalidomide and Rituximab for Follicular Lymphoma: a Single Institution Experience From the Phase 3 inMIND Study

Danielle Janiszewski

Poster Presenter: Danielle Janiszewski

Video